Julia Hu is an American entrepreneur and the co-founder and CEO of Lark. Founded on the personal experience of having grown up with an undiagnosed chronic condition, Julia is passionate about bringing compassionate care to those struggling with or at risk of chronic disease. Hu was named one of the “Top 10 Women in Tech” by Forbes and was a winner of Inc. Magazine’s “30 under 30”. Prior to founding Lark in 2011, Julia ran global startup incubator, the Clean Tech Open, built a sustainable construction startup, and was an Entrepreneur-in-Residence at Stanford’s StartX incubator. She is on the board of the Council for Diabetes Prevention and a Singularity University faculty member. Hu received her Master’s and Bachelor’s degrees at Stanford University and half of an MBA from MIT Sloan before founding Lark. Julia loves to stay fit with hip hop.

As the technical cofounder, Jeff is continuing to discover how to apply technology to bring humanity and connection to people with chronic conditions. Prior to Lark, Jeff co-founded and sold a social networking startup in Japan, co-founded Sanergy, the waterless sanitation startup at MIT that now has 250 employees, architected the backend tools to improve Kiva’s microfinance platform, and Product Managed Yahoo.com’s homepage. Jeff has a BS from UC Santa Barbara and MBA from MIT Sloan. When possible, Jeff spends at least one whole day each weekend meditating.

Ms. Edwards is an innovative pioneer in Digital Health and Telecommunications, stemming from her unique assignments in her early career at Stanford Research Center, continuing through rapid promotions as she successfully commercialized as a senior executive at Bell Canada – Enterprises to VP Sales at NorTel Networks to ATT to CEO at Middlewire, a venture-backed startup.

‍

At Bell Canada, she turned a critical research project into a commercial venture, the first Information System Network in North America, before heading corporate sales for National Accounts. 

‍

At NorTel Networks, she employed NorTel’s unique network capabilities – core, edge and wireless – enabling and introducing new consumer applications, and driving sales for their largest distributor.

‍

She formed the first Healthcare Market organization in the ATT Bell System Operating Companies, focused in determining needs and requirements of the future healthcare ecosystem, driving innovation in both technologies and service models, enabling AND providing new capabilities for telemedicine and digital health applications.

‍

She convened annual multi-day leadership roundtables with CEOs, CMOs and CIOs of the top 20 health care delivery institutions  and major insurers, Aetna, Blue Cross / Blue Shield  for 5 consecutive years, seeking industry input and support for the drivers of change, and consensus of requirements,  securing their commitment to partnerships. A major innovation at the time, these meetings convened industry thought leaders such as Molly Coy, MD, Eric Topol, MD, and Kim Belshe.

‍

Through these partnerships and the resulting mutual understandings between the healthcare ecosystem and the telecommunications providers, Gwen drove key telemedicine and digital health applications from early days of NIH funded applied research to commercial trials with UCSF, Sutter Health, John Muir, and Scripps. She further served for 18 years on the Board of the National Health Foundation, driving the development of a California wide network that led to CHIN (California Health Information Network).

‍

Active on many fronts, Gwen: drafted the first Telemedicine Legislation for the State of California; was part of Surgeon General’s C E Koop’s Round Table; met with then First Lady H. Clinton during her formulation of the Clinton Health Initiative; and formally advised FCC Commissioners on bandwidth requirements for telehealth.

‍

As the available technology increased and evolved – such as highly distributed, high capacity broadband networks – Gwen had system definition and operating responsibilities, becoming President (with P&L responsibility) for the Network Integration Business Unit of the ATT Corporation, where her unit was named by Cisco as “Fastest Growing Reseller” of the year.

‍

Gwen now invests her knowledge, networks, and operating experience into high growth companies in tech that matters, and at the intersection of tech / AI / health / life sciences.  

‍

Involved in the IPO of TCBioPharma and Tivic Health, she has investments in Lark Health, Materna Health, ConcertoCare (with Steel Sky Ventures), Jurata Thin Film, Concerto Biosciences, Sisu Global Health, Rivia Health, OtoNexus, Sunray Scientific, and was a proud early backer of nVision, purchased by Boston Scientific). 

‍

Gwen also spends significant time coaching and mentoring many of these companies. She is passionate about advancing positive social impact, gender parity, and greater transparency in governance.

‍

As Chair of the Angel Resource Institute, Gwen teaches Board Governance for early investors.

‍

Gwen holds degrees from University of California (BA), California State University (MA) and Pepperdine University (MBA).  

Danielle Russella is a 25+ year healthcare veteran with deep domain experience in commercial and government markets, client portfolio growth, business transformation, and creating high-performing client facing teams. She’s built several companies from the ground up with a focus on global sales and enterprise distribution, strategic partnerships, joint ventures, and all facets of go-to-market. Danielle led several companies through extraordinary growth, was a founding Board Director of the National Telehealth Provider Network, and had extensive roles in several companies that went public, including Amwell’s IPO in 2020 (NYSE:AMWL). 

‍

Today Danielle is a Venture & Board Chair at Redesign Health where she lends her expertise to Redesign Operating Companies. In this role she works with companies from their earliest days when the business is only an idea, recruits the CEO and founding team, and partners alongside founding CEOs to develop, build, publicly launch and scale their businesses. 

‍

Most recently, Danielle was with national telehealth leader Amwell. She joined the company at its inception in 2007, helping Amwell enter and lead in multiple markets. She held a number of executive roles including President of Strategic Partnerships, as well as President for the company’s segment-focused Payer, Health System and Employer business units. Prior to Amwell, Danielle held leadership positions at several healthcare and technology companies including MEDecision, Hewlett-Packard, and Bluestone Software, with earlier days spent as an investment banker at Wells Fargo. 

‍

Danielle received her B.S. in Finance from Drexel University and holds Series 7 & 63 Broker Licenses. Danielle serves on the Boards of Navigating Cancer, Lark, Together Senior Health, TempoPay, and Baton Health. She is a sought-after speaker on topics ranging from technology as an enabler to new models of care delivery. She is heavily involved in several student/young adult mentor programs as well as local and national DE&I and social service  initiatives.

Jonathan Fielding is a Distinguished Professor of Health Policy and Management and of Pediatrics in the Schools of Public Health and Medicine at UCLA. Dr. Fielding is an expert in public health preparedness and communications. He served as Massachusetts Commissioner of Public Health and for 16 years as Public Health Director and Health Officer for Los Angeles County. In this capacity, he was responsible for the county’s public health response to numerous infectious disease threats. He served as a founding member of the U.S. Clinical Preventive Services Task Force and, for 17 years, as Chair of the U.S. Task Force on Community Preventive Services.

‍
He chaired the Advisory Committee for the U.S. Healthy People 2020 objectives and is currently Co-Chair for the Healthy People 2030 objectives. He was appointed by President Barak Obama to the National Advisory Group on Prevention, Health Promotion and Integrative and Public Health, and is an elected member of the National Academy of Medicine.
‍
Dr. Fielding founded the UCLA Center for Health Advancement, which models policies and programs to cost-effectively improve health and health equity and also researches waste in medical care. He is also a founder and co-director of the UCLA Center for Healthy Climate Solutions, which focuses on protecting human health from the harmful effects of climate change. He has authored or coauthored more than 300 original articles, commentaries, editorials and chapters on various aspects of public health, preventive medicine, health services, and health economics. He is the longstanding editor of the Annual Review of Public Health and currently writes a monthly opinion column on health issues for The Hill.
‍
Dr. Fielding holds MD, MPH, and MA degrees from Harvard University and an MBA from the Wharton School, University of Pennsylvania. His honors include the UCLA Medal, the Sedgwick Medal, and the Roemer, Fries and Porter prizes, as well as honorary doctorates. The UCLA Fielding School of Public Health is named for him and his wife Karin.

‍

Robert A. Gabbay, MD, PhD, has 20 years of clinical and research experience and is Chief Medical Officer and Senior Vice President at Joslin Diabetes Center. His research focuses on improving primary care health care delivery to enhance diabetes outcomes and patients’ experiences.

‍

Dr. Gabbay served as faculty chair of Pennsylvania’s statewide Chronic Care Model-focused Patient Centered Medical Home (PCMH) initiative (Chronic Care Initiative) involving more than 150 primary care practices with support from 17 payers.

‍

Throughout his career, Dr. Gabbay has been committed to providing the best quality possible to diabetes patients while exceeding the highest national clinical quality measures.